Gradient Investments LLC Verastem, Inc. Transaction History

Gradient Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 10, 2020	SELL	$1.69 - $4.2 $6,499 - $16,153	-3,846 Closed	0 $0
Q2 2019 Jul 16, 2019	BUY	$1.25 - $3.14 $4,807 - $12,076	3,846 New	3,846 $6,000
Q2 2018 Aug 09, 2018	SELL	$2.88 - $8.67 $2,880 - $8,670	-1,000 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$2.99 - $4.85 $2,990 - $4,850	1,000	1,000 $3,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.